Search
Results: 7
Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer.
Vincent J Gnanapragasam, Tristan Barrett, Vineetha Thankapannair, David Thurtle, Jose Rubio-Briones, Jose Domínguez-Escrig, Ola Bratt, Par Statin, Kenneth Muir, Artitaya Lophatananon
May 10, 2019
OBJECTIVES: To test whether using disease prognosis can inform a rational approach to active surveillance (AS) for early prostate cancer. PATIENTS AND METHODS: We previously developed the Cambridge Prognostics Groups (CPG)...
Progression and treatment rates using an active surveillance protocol incorporating image-guided baseline biopsies and multiparametric magnetic resonance imaging monitoring for men with favourable-risk prostate cancer.
David Thurtle, Tristan Barrett, Vineetha Thankappan-Nair, Brendan Koo, Anne Warren, Christof Kastner, Kasra Saeb-Parsy, Jenna Kimberley-Duffell, Vincent J Gnanapragasam
Apr 26, 2018
OBJECTIVE: To assess early outcomes since the introduction of an active surveillance (AS) protocol incorporating multiparametric magnetic resonance imaging (mpMRI)-guided baseline biopsies and image-based surveillance. PATIENTS...
#PCSM #ProstateCancer active surveillance localized prostate cancer low-risk prostate cancer mpMRI Aged Aged 80 and over Disease Progression Humans Image-guided biopsy Magnetic Resonance Imaging Interventional Male Middle Aged Prospective Studies Prostate Prostate-specific antigen Prostatic Neoplasms Retreatment Treatment Outcome Watchful Waiting
Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy.
Nienke L Hansen, Claudia Kesch, Tristan Barrett, Brendan Koo, Jan P Radtke, David Bonekamp, Heinz-Peter Schlemmer, Anne Y Warren, Kathrin Wieczorek, Markus Hohenfellner, Christof Kastner, Boris Hadaschik
Feb 02, 2017
#PCSM #ProstateCancer image fusion Magnetic Resonance Imaging prostate biopsy prostate cancer prostate-specific antigen density transperineal biopsy Aged Humans Image-guided biopsy Magnetic Resonance Imaging Interventional Male Middle Aged Predictive Value of Tests Prospective Studies Prostate Prostatic Neoplasms Ultrasonography Interventional
Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations.
Elizabeth K Bancroft, Sibel Saya, Elizabeth C Page, Kathryn Myhill, Sarah Thomas, Jennifer Pope, Anthony Chamberlain, Rachel Hart, Wayne Glover, Jackie Cook, Derek J Rosario, Brian T Helfand, Christina Hutten Selkirk, Rosemarie Davidson, Mark Longmuir, Diana M Eccles, Neus Gadea, Carole Brewer, Julian Barwell, Monica Salinas, Lynn Greenhalgh, Marc Tischkowitz, Alex Henderson, David Gareth Evans, Saundra S Buys, IMPACT Study Steering Committee, IMPACT Collaborators, Rosalind A Eeles, Neil K Aaronson
Feb 07, 2020
OBJECTIVES: To report the baseline results of a longitudinal psychosocial study that forms part of the IMPACT study, a multi-national investigation of targeted prostate cancer (PCa) screening among men with a known pathogenic...
BRCA1 BRCA2 #ProstateCancer #PCSM Psychosocial Quality of life Adult Anxiety Case-Control Studies Depression Early Detection of Cancer Genes BRCA1 Genes BRCA2 Health Knowledge Attitudes practice Humans Longitudinal Studies Male Middle Aged Mutation Perception Prostatic Neoplasms Psychiatric Status Rating Scales Quality of life Risk Factors Surveys and Questionnaires
Best practice in Active Surveillance for men with prostate cancer
Samuel WD Merriel, Liz Hetherington, Andrew Seggie, Joanna T Castle, William Cross, Monique J Roobol, Vincent Gnanapragasam, Caroline M Moore, Prostate Cancer UK Expert Reference Group on Active Surveillance
Apr 04, 2019
OBJECTIVES: To develop a consensus statement on current best practice of active surveillance (AS) in the UK, informed by patients and clinical experts. SUBJECTS AND METHODS: A consensus statement was drafted on the basis of...
Optimising the number of cores for magnetic resonance imaging-guided targeted and systematic transperineal prostate biopsy.
Nienke L Hansen, Tristan Barrett, Thomas Lloyd, Anne Warren, Christina Samel, Ola Bratt, Christof Kastner
Jul 24, 2019
OBJECTIVES: To assess cancer detection rates of different target-dependent transperineal magnetic resonance (MR)/ultrasonography (US) fusion-guided biopsy templates with reduced number of systematic cores. PATIENTS AND METHODS...
#PCSM #ProstateCancer MRI-TRUS fusion Magnetic Resonance Imaging prostate biopsy Transperineal Aged Humans Image-guided biopsy Magnetic Resonance Imaging Interventional Male Middle Aged Neoplasm Grading Perineum Prospective Studies Prostate Prostatic Neoplasms Reproducibility of Results Ultrasonography Interventional